Inactive Instrument

Institute of Biomedical Research Corp. Stock Other OTC

Equities

MRES

US45781A1079

Dynamic Chart
Institute of Biomedical Research Corp. Introduces M2BioKids CI
Real American Capital Corp. acquired M2MMA from Institute of Biomedical Research Corp.. CI
Institute of Biomedical Research Corp. Appoints Victor Lange as CEO of M2MMA CI
Institute of Biomedical Research Corp. acquired JDAX. CI
Institute of Biomedical Research Corp. Presents Update on its Latest Scientific Endeavor: M2Bio Sciences Endeavors to Usher in a Paradigm Shift Within the Realm of Medical Health by Focusing on the Foundational Facet of Drug Discovery CI
Institute of Biomedical Research Corp. Appoints Ze-Ev Krein, an Interdisciplinary Scientist, and M2bio Scientific Advisory Board Chairman CI
Institute of Biomedical Research Corp. Unveils a Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits CI
Institute of Biomedical Research Corp. signed a letter of intent to acquire JDAX. CI
Institute of Biomedical Research Corp. Establishes Research Chair At the University of Pretoria for Phytomedicines CI
Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN). CI
Institute of Biomedical Research Corp. acquired Travel Mix Group Inc. CI
Neuro-Biotech Corp. will Change its Name to The Institute of Biomedical Research Corp CI
Institute of Biomedical Research acquired Neuro-Biotech Corp. in a reverse merger transaction. CI
More news
Managers TitleAgeSince
Chief Executive Officer - 22-07-10
Director of Finance/CFO 66 -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Executive Officer - 22-07-10
Director of Finance/CFO 66 -
More insiders